Bryan Johnson, the 45-year-old tech entrepreneur behind Braintree, is spending roughly $2 million a year in a highly publicized effort to reverse his biological age to that of an 18-year-old. His regimen, detailed by Bloomberg, includes a team of over 30 doctors and health professionals, a strict diet and supplement plan, and a series of often painful procedures, all aimed at achieving youthful biomarkers across his entire body.
Johnson's approach is notably transparent. He maintains a public document called Blueprint, which functions as a fitness tracker and personal diary, recording everything from his monthly food costs to his 'notable challenges' and guiding principles. This openness is unusual among wealthy longevity enthusiasts, who often keep such efforts private. Johnson's stated motivation, as per Blueprint's landing page, is to combat entropy and 'maintain perpetual youth' by slowing and reversing aging.
His team reports significant results. According to Bloomberg, his doctors believe his heart, skin, and lung capacity now present as 37, 28, and 18 years old, respectively. Over seven months, they claim his epigenetic clock has been wound back by 5.1 years. Jeff Toll, an internist on Johnson's staff, told Bloomberg that 'all of the markers we are tracking have been improving remarkably,' and that no other client, including athletes and celebrities, pushes the envelope as far as Johnson does.
Extreme Measures and Daily Routines
Johnson's routine is anything but ordinary. He has taken over 33,537 photos of his bowel movements, undergoes frequent blood, stool, and urine tests, and receives whole-body MRIs and ultrasounds. His daily skincare regimen involves lasers and chemical peels, and he even uses a device to track nighttime erections. These measures, while extreme, underscore his commitment to his goal of achieving 'age 18 everywhere,' as he told Bloomberg.
Johnson's quest is part of a broader trend among the ultrawealthy, particularly in Silicon Valley, to extend lifespan and vitality. However, his willingness to share his data and methods sets him apart. He insists his efforts are not about commercial gain but personal curiosity and a desire to prove that 'self-harm and decay are not inevitable.'
While the scientific community remains cautious about such claims, Johnson's project offers a rare, data-rich case study in extreme biohacking. His Blueprint document, with its detailed tracking and philosophical musings, provides a glimpse into the mindset of someone willing to spend millions to turn back the clock.
